These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35852914)

  • 1. Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn's disease patients under anti-tumor necrosis factor-α treatment.
    Stavrou EF; Chatzopoulou F; Antonatos C; Pappa P; Makridou E; Oikonomou K; Kapsoritakis A; Potamianos PS; Karmiris K; Tzathas C; Chatzidimitriou D; Vizirianakis IS; Vasilopoulos Y
    Pharmacogenet Genomics; 2022 Aug; 32(6):235-241. PubMed ID: 35852914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease.
    Netz U; Carter JV; Eichenberger MR; Dryden GW; Pan J; Rai SN; Galandiuk S
    World J Gastroenterol; 2017 Jul; 23(27):4958-4967. PubMed ID: 28785150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predictors of long-term response and trough levels of infliximab in crohn's disease.
    Salvador-Martín S; López-Cauce B; Nuñez O; Laserna-Mendieta EJ; García MI; Lobato E; Abarca-Zabalía J; Sanjurjo-Saez M; Lucendo AJ; Marín-Jiménez I; Menchén LA; López-Fernández LA
    Pharmacol Res; 2019 Nov; 149():104478. PubMed ID: 31605784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's Disease.
    Mortensen JH; van Haaften WT; Karsdal MA; Bay-Jensen AC; Olinga P; Grønbæk H; Hvas CL; Manon-Jensen T; Dijkstra G; Dige A
    J Clin Gastroenterol; 2021 Jan; 55(1):59-66. PubMed ID: 32301833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn's disease.
    Thomas D; Gazouli M; Karantanos T; Rigoglou S; Karamanolis G; Bramis K; Zografos G; Theodoropoulos GE
    World J Gastroenterol; 2014 Apr; 20(13):3609-14. PubMed ID: 24707144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.
    Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Rasmussen BK; Avlund S; Olesen TB; Hoffmann HJ; Thomsen MK; Thomsen VØ; Frydenberg M; Nexø BA; Sode J; Vogel U; Andersen V
    Pharmacogenomics J; 2014 Dec; 14(6):526-34. PubMed ID: 24776844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
    Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
    Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease.
    Karmi N; Bangma A; Spekhorst LM; van Dullemen HM; Visschedijk MC; Dijkstra G; Weersma RK; Voskuil MD; Festen EAM
    PLoS One; 2021; 16(9):e0256860. PubMed ID: 34534227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
    Luther J; Gala M; Patel SJ; Dave M; Borren N; Xavier RJ; Ananthakrishnan AN
    Dig Dis Sci; 2018 Mar; 63(3):738-745. PubMed ID: 29372477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
    Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
    Salvador-Martín S; Raposo-Gutiérrez I; Navas-López VM; Gallego-Fernández C; Moreno-Álvarez A; Solar-Boga A; Muñoz-Codoceo R; Magallares L; Martínez-Ojinaga E; Fobelo MJ; Millán-Jiménez A; Rodriguez-Martinez A; Vayo CA; Sánchez C; Tolin M; Bossacoma F; Pujol-Muncunill G; González de Caldas R; Loverdos I; Blanca-García JA; Segarra O; Eizaguirre FJ; García-Romero R; Merino-Bohórquez V; Sanjurjo-Sáez M; López-Fernández LA
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.
    Chaparro M; Guerra I; Iborra M; Cabriada JL; Bujanda L; Taxonera C; García-Sánchez V; Marín-Jiménez I; Barreiro-de Acosta M; Vera I; Martín-Arranz MD; Hernández-Breijo B; Mesonero F; Sempere L; Gomollón F; Hinojosa J; Bermejo F; Beltrán B; Rodríguez Pescador A; Banales JM; Olivares D; Aguilar-Melero P; Menchén L; Ferreiro-Iglesias R; Blazquez Gomez I; Benítez García B; Guijarro LG; Marin A; Bernardo D; Gisbert JP;
    Eur J Gastroenterol Hepatol; 2020 May; 32(5):588-596. PubMed ID: 32251204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Ma C; Beilman CL; Huang VW; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    Inflamm Bowel Dis; 2016 Apr; 22(4):870-9. PubMed ID: 26818419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of response to anti-tumor necrosis factor therapy in patients with Crohn's disease.
    Shetty A; Forbes A
    Am J Pharmacogenomics; 2002; 2(4):215-21. PubMed ID: 12421092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.
    Lacruz-Guzmán D; Torres-Moreno D; Pedrero F; Romero-Cara P; García-Tercero I; Trujillo-Santos J; Conesa-Zamora P
    Eur J Clin Pharmacol; 2013 Mar; 69(3):431-8. PubMed ID: 22960943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
    Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.
    Barreiro-de Acosta M; Ouburg S; Morré SA; Crusius JB; Lorenzo A; Potel J; Salvador-Peña A; Domínguez-Muñoz JE
    Rev Esp Enferm Dig; 2010 Oct; 102(10):591-5. PubMed ID: 21039068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.
    D'Amico F; Peyrin-Biroulet L; Vandromme L; Bouhnik Y; Faure P; Nahon S; Hagege H; Hebuterne X; Benkhalifa S; Nachury M
    Dig Liver Dis; 2020 Sep; 52(9):995-1001. PubMed ID: 32532602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn's disease: a systematic review and meta-analysis.
    Wang X; Qin L; Cao J; Zhao J
    Curr Med Res Opin; 2016 Dec; 32(12):2007-2012. PubMed ID: 27533749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.